Best Castleman Disease Treatment Hospitals Worldwide

NMC Specialty Hospital provides Castleman Disease Treatment using contemporary haematology and immunotherapy approaches, along with evidence-based care. Founded in 1975, the JCI, NABH accredited hospital is based in Abu Dhabi, United Arab Emirates, with 104 beds and services for domestic and international patients.

The treatment approach depends on the subtype and severity of the disease. For unicentric Castleman disease, complete surgical removal may be sufficient in many cases. Multicentric disease may require systemic therapy, including medicines that target inflammatory pathways, corticosteroids, or other treatments based on the underlying cause and clinical presentation.

HE Clinic offers advanced Castleman Disease Treatment using modern diagnostic and therapeutic approaches and internationally accepted treatment protocols. Established in 2013, the NABH accredited hospital is located in Bangkok, Thailand, with beds, providing comprehensive care for local and international patients.

Treatment depends on the type of Castleman disease, number of affected lymph node regions, symptoms, and associated conditions. Localised unicentric disease may often be treated with surgical removal of the affected lymph node, while multicentric disease may require medicines such as immunotherapy, corticosteroids, or other systemic treatments. Detailed evaluation helps determine the appropriate approach.

Lokman Hekim Esnaf Hospital offers advanced Castleman Disease Treatment using modern diagnostic and therapeutic approaches and internationally accepted treatment protocols. Established in 1997, the JCI accredited hospital is located in Fethiye, Turkey, with 75 beds, providing comprehensive care for local and international patients.

Treatment depends on the type of Castleman disease, number of affected lymph node regions, symptoms, and associated conditions. Localised unicentric disease may often be treated with surgical removal of the affected lymph node, while multicentric disease may require medicines such as immunotherapy, corticosteroids, or other systemic treatments. Detailed evaluation helps determine the appropriate approach.

Bukit Tinggi Medical Centre offers specialised Castleman Disease Treatment using modern diagnostic technology and established haematology treatment protocols. Established in 2016, the MSQH accredited hospital is situated in Kuala Lumpur, Malaysia, with 171 beds, serving local and international patients.

Treatment is personalised according to the disease subtype, extent, symptoms, and underlying cause. Surgery may be recommended for unicentric disease when the affected lymph node can be safely removed, while multicentric forms may require targeted immunotherapy or other systemic medicines. Before treatment, the multidisciplinary team conducts imaging, lymph-node evaluation, blood tests, and other investigations to develop an appropriate treatment plan.

Fortis Hiranandani Hospital offers advanced Castleman Disease Treatment using modern diagnostic and therapeutic approaches and internationally accepted treatment protocols. Established in 2007, the NABH accredited hospital is located in Mumbai, India, with 149 beds, providing comprehensive care for local and international patients.

Treatment depends on the type of Castleman disease, number of affected lymph node regions, symptoms, and associated conditions. Localised unicentric disease may often be treated with surgical removal of the affected lymph node, while multicentric disease may require medicines such as immunotherapy, corticosteroids, or other systemic treatments. Detailed evaluation helps determine the appropriate approach.

With advanced haematology and oncology infrastructure, Jaypee Hospital offers Castleman Disease Treatment for patients requiring specialised management of this rare lymph-node disorder. Established in 2014, the NABH, JCI accredited hospital is located in Noida, India, and has 1200 beds.

For localised unicentric disease, treatment may involve surgical removal of the affected lymph node. Patients with multicentric disease may require systemic therapies, including anti-IL-6 therapy, other immunotherapies, corticosteroids, or chemotherapy in selected situations. Specialists assess lymph-node pathology, laboratory findings, symptoms, and associated infections or immune conditions before treatment.

At Fortis Hospital, Shalimar Bagh, patients can access comprehensive Castleman Disease Treatment supported by advanced diagnostic facilities and experienced specialists. Established in 2010, the NABH accredited hospital is located in Delhi, India, and has 262 beds.

Castleman disease treatment is tailored according to whether the condition is unicentric or multicentric and whether an underlying infection or immune disorder is present. Surgery may be used for localised disease, while multicentric forms may require antibody-based therapy, corticosteroids, chemotherapy, or treatment of an associated condition. A thorough diagnostic assessment guides treatment selection.

Seven Hills Hospital offers advanced Castleman Disease Treatment using modern diagnostic and therapeutic approaches and internationally accepted treatment protocols. Established in 1986, the NABH, NABL, JCI accredited hospital is located in Mumbai, India, with 1500 beds, providing comprehensive care for local and international patients.

Treatment depends on the type of Castleman disease, number of affected lymph node regions, symptoms, and associated conditions. Localised unicentric disease may often be treated with surgical removal of the affected lymph node, while multicentric disease may require medicines such as immunotherapy, corticosteroids, or other systemic treatments. Detailed evaluation helps determine the appropriate approach.

Sri Ramachandra Medical Centre offers specialised Castleman Disease Treatment using modern diagnostic technology and established haematology treatment protocols. Established in 1985, the JCI, NABH accredited hospital is situated in Chennai, India, with 1800 beds, serving local and international patients.

Treatment is personalised according to the disease subtype, extent, symptoms, and underlying cause. Surgery may be recommended for unicentric disease when the affected lymph node can be safely removed, while multicentric forms may require targeted immunotherapy or other systemic medicines. Before treatment, the multidisciplinary team conducts imaging, lymph-node evaluation, blood tests, and other investigations to develop an appropriate treatment plan.

Max Smart Super Speciality Hospital provides Castleman Disease Treatment using contemporary haematology and immunotherapy approaches, along with evidence-based care. Founded in 2012, the JCI, NABH accredited hospital is based in Delhi, India, with 250 beds and services for domestic and international patients.

The treatment approach depends on the subtype and severity of the disease. For unicentric Castleman disease, complete surgical removal may be sufficient in many cases. Multicentric disease may require systemic therapy, including medicines that target inflammatory pathways, corticosteroids, or other treatments based on the underlying cause and clinical presentation.

At Acibadem Kadikoy Hospital, patients can access comprehensive Castleman Disease Treatment supported by advanced diagnostic facilities and experienced specialists. Established in 1991, the JCI accredited hospital is located in Istanbul, Turkey, and has 138 beds.

Castleman disease treatment is tailored according to whether the condition is unicentric or multicentric and whether an underlying infection or immune disorder is present. Surgery may be used for localised disease, while multicentric forms may require antibody-based therapy, corticosteroids, chemotherapy, or treatment of an associated condition. A thorough diagnostic assessment guides treatment selection.

Tel Aviv Sourasky Medical Center -Ichilov Hospital provides Castleman Disease Treatment using contemporary haematology and immunotherapy approaches, along with evidence-based care. Founded in 1963, the JCI accredited hospital is based in Tel Aviv, Israel, with 1500 beds and services for domestic and international patients.

The treatment approach depends on the subtype and severity of the disease. For unicentric Castleman disease, complete surgical removal may be sufficient in many cases. Multicentric disease may require systemic therapy, including medicines that target inflammatory pathways, corticosteroids, or other treatments based on the underlying cause and clinical presentation.

Apollo Spectra Hospital offers specialised Castleman Disease Treatment using modern diagnostic technology and established haematology treatment protocols. Established in 2012, the NABH, NABL accredited hospital is situated in Pune, India, with 30 beds, serving local and international patients.

Treatment is personalised according to the disease subtype, extent, symptoms, and underlying cause. Surgery may be recommended for unicentric disease when the affected lymph node can be safely removed, while multicentric forms may require targeted immunotherapy or other systemic medicines. Before treatment, the multidisciplinary team conducts imaging, lymph-node evaluation, blood tests, and other investigations to develop an appropriate treatment plan.

Amrita Hospital offers specialised Castleman Disease Treatment using modern diagnostic technology and established haematology treatment protocols. Established in 2022, the NABH accredited hospital is situated in Faridabad, India, with 2600 beds, serving local and international patients.

Treatment is personalised according to the disease subtype, extent, symptoms, and underlying cause. Surgery may be recommended for unicentric disease when the affected lymph node can be safely removed, while multicentric forms may require targeted immunotherapy or other systemic medicines. Before treatment, the multidisciplinary team conducts imaging, lymph-node evaluation, blood tests, and other investigations to develop an appropriate treatment plan.

At The Alexandra Hospital, patients can access comprehensive Castleman Disease Treatment supported by advanced diagnostic facilities and experienced specialists. Established in 1981, the NABH accredited hospital is located in Cheadle, United Kingdom, and it has adequate bed capacity.

Castleman disease treatment is tailored according to whether the condition is unicentric or multicentric and whether an underlying infection or immune disorder is present. Surgery may be used for localised disease, while multicentric forms may require antibody-based therapy, corticosteroids, chemotherapy, or treatment of an associated condition. A thorough diagnostic assessment guides treatment selection.